Sponsored Links

Hematology
Title Filter     Display # 
# Article Title
1 Remission Duration Of Lymphoma Doubled By New Therapy
2 Stem Cell Transplantation: A New Strategy For Treating Multiple Myeloma
3 New Therapeutic Agent In Development Shows Statistically Significant Positive Outcomes In Patients With Debilitating, Life-threatening Blood Cancer
4 Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity In Patients With Relapsed Acute Lymphoblastic Leukemia
5 U-M Researchers Find Potential New Way To Fight Sepsis
6 Blinatumomab Achieved 75% Complete Remission In Acute Relapsing Lymphoblastic Leukemia Patients
7 Symphogen Presents Preliminary Results From Phase 2 Clinical Trial With Rozrolimupab At The Annual European Hematology Association
8 Avila Therapeutics Presents Data Demonstrating The Relevance Of Its Btk Inhibitor, AVL-292, In B Cell Malignancies Such As CLL
9 Researchers Present Final Data From Phase 2 Studies Of Soliris(R) (Eculizumab) In Patients With AHUS
10 New Data Show Renal Impairment Is Strong Predictor Of Early Death In Patients With PNH
11 Millennium And Seattle Genetics Present Clinical Data On ADCETRIS™ (Brentuximab Vedotin) In Hodgkin Lymphoma At EHA Annual Meeting
12 Decoding Chronic Lymphocytic Leukemia
13 Interim Data From Phase 2 Trial Of AC220 Monotherapy In Patients With Relapsed Or Refractory Acute Myeloid Leukemia With FLT3-ITD Activating Mutations
14 SMC Approves Ferinject (Ferric Carboxymaltose) For The Treatment Of Iron Deficiency Anaemia
15 New Study Into Blood Risk To Contribute To National Policy Debate
16 Canadian Blood Services Issues Rallying Cry To Canadians
17 Voluntary Unpaid Blood Donations Increase, Saving More Lives
18 Shedding New Light On How Blood Clots Form
19 Towards A More Efficient Therapy For A Specific Form Of Leukemia
20 OrSense's Non Invasive Hemoglobin Monitor Has The Potential To Enhance Recruitment Of Blood Donors
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 23
Copyright (C) 2009 MedicalMarket.info